NCT01803282 Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01802645 Cetuximab/FOLFIRI With or Without Oxaliplatin and FOLFOXIRI With or Without Bevacizumab in Neoadjuvant Treatment of Non-resectable Colorectal Liver Metastases Status UNKNOWN Phase PHASE2
NCT01798251 XELOX With Capecitabine Maintenance or XELOX in Elderly Metastatic Adenocarcinoma of Stomach Status UNKNOWN Phase PHASE2
NCT01769508 Study of 5-FU, Oxaliplatin, & Lapatinib Combined With Radiation Therapy to Treat HER2 Positive Esophagogastric Cancer Status TERMINATED Phase PHASE2
NCT01765582 Sequential and Concurrent FOLFOXIRI/Bevacizumab Regimens Versus FOLFOX/Bevacizumab in First-Line Metastatic Colorectal Cancer Status TERMINATED Phase PHASE2
NCT01748773 A Study of the Combination of Oxaliplatin, Capecitabine, and Trastuzumab With Chemoradiotherapy in the Adjuvant Setting in Operated Participants With Human Epidermal Growth Factor Receptor-2 Positive (HER2+) Gastric or Gastroesophageal Junction Cancer Status COMPLETED Phase PHASE2
NCT01747551 FOLFOX +/- Ziv-Aflibercept for Esophageal and Gastric Cancer Status COMPLETED Phase PHASE2
NCT01732380 A Phase-II Study Of Raltitrexed/Oxaliplatin Plus Radiotherapy Versus Radiotherapy In Subjects With Inoperable Esophageal Cancer Status UNKNOWN Phase PHASE2
NCT01729481 Gemcitabine Plus Erlotinib in RASH-positive Patients With Metastatic Pancreatic Cancer Status UNKNOWN Phase PHASE2
NCT01726452 NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study (Neo-AEGIS) Status COMPLETED Phase PHASE3
NCT01718873 Optimization of Bevacizumab Scheduling With Chemotherapy for Metastatic Colorectal Cancer Status COMPLETED Phase PHASE3
NCT01716949 Neoadjuvant Chemoradiation With 5-FU(or Capecitabine) and Oxaliplatin Combined With Hyperthermia in Rectal Cancer Status UNKNOWN Phase PHASE1/PHASE2
NCT01715363 Feasibility of an Immediate Preoperative Chemotherapy Before Resection fo Colorectal Cancer Status TERMINATED Phase PHASE2
NCT01711242 Trial of Adjuvant XELOX Chemotherapy and Concurrent Capecitabine and Radiotherapy for Resected Gastric Carcinoma Status COMPLETED Phase PHASE2
NCT01710592 A Phase II Trial of Epirubicin, Oxaliplatin and Capecitabine (EOX) Versus Docetaxel and Oxaliplatin (ElTax) in the Treatment of Advanced Gastro-oesophageal Cancer Status COMPLETED Phase PHASE2
NCT01679340 A PhaseⅡ Study: SOX vs SP in Adjuvant Chemotherapy After D2 Surgery Status UNKNOWN Phase PHASE2
NCT01679327 Study of Bevacizumab Plus Chemotherapy in Patients With Metastatic Colorectal Cancer Status UNKNOWN Phase PHASE2
NCT01671449 S-1 and Cisplatin (3 Weekly) Versus S-1 and Oxaliplatin Combination Chemotherapy for Advanced Gastric Cancer Status COMPLETED Phase PHASE3
NCT01666730 Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE2